Free Trial
LON:DXRX

Diaceutics (DXRX) Share Price, News & Analysis

Diaceutics logo
GBX 116 -2.00 (-1.69%)
As of 11:31 AM Eastern

About Diaceutics Stock (LON:DXRX)

Key Stats

Today's Range
114
116
50-Day Range
113
140
52-Week Range
106
151
Volume
404,149 shs
Average Volume
129,062 shs
Market Capitalization
£97.90 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
GBX 160
Consensus Rating
Buy

Company Overview

At Diaceutics we believe that every patient should get the opportunity to receive the right test and the right therapy to positively impact their disease outcome. We provide the world's leading pharma and biotech companies with an end-to-end commercialisation solution for precision medicines through data analytics, scientific and advisory services enabled by our platform DXRX - The Diagnostics Network®.

Receive DXRX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Diaceutics and its competitors with MarketBeat's FREE daily newsletter.

DXRX Stock News Headlines

Everyone’s watching Nvidia right now. Here’s why I’m excited.
So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal with Saudi Arabia to power its new AI empire 🤯 We’re talking about hundreds of thousands of chips, including their latest Grace Blackwell supercomputer.
See More Headlines

DXRX Stock Analysis - Frequently Asked Questions

Diaceutics' stock was trading at GBX 123 at the beginning of the year. Since then, DXRX stock has decreased by 5.7% and is now trading at GBX 116.
View the best growth stocks for 2025 here
.

Diaceutics PLC (LON:DXRX) issued its quarterly earnings data on Tuesday, May, 13th. The company reported ($2.02) earnings per share for the quarter. Diaceutics had a negative trailing twelve-month return on equity of 7.15% and a negative net margin of 10.90%.

Shares of DXRX stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

Based on aggregate information from My MarketBeat watchlists, some other companies that Diaceutics investors own include 4D pharma (DDDD), Rolls-Royce Holdings plc (RR.L), Abcam (ABC), B&M European Value Retail (BME), BP (BP), Coats Group (COA) and genedrive (GDR).

Company Calendar

Last Earnings
5/13/2025
Today
6/23/2025

Industry, Sector and Symbol

Stock Exchange
LON
Sector
Medical
Industry
Diagnostics & Research
Sub-Industry
N/A
Current Symbol
LON:DXRX
CIK
N/A
Phone
N/A
Fax
N/A
Employees
151
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
GBX 160
High Stock Price Target
GBX 160
Low Stock Price Target
GBX 160
Potential Upside/Downside
+39.1%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
2 Analysts

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
113.77
P/E Growth
N/A
Net Income
-£2.84 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
£26.08 million
Cash Flow
GBX 36.86 per share
Price / Cash Flow
3.12
Book Value
GBX 45.87 per share
Price / Book
2.51

Miscellaneous

Free Float
N/A
Market Cap
£97.05 million
Optionable
Not Optionable
Beta
0.58
Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report

This page (LON:DXRX) was last updated on 6/23/2025 by MarketBeat.com Staff
From Our Partners